Overview

Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure

Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of resatorvid on subjects with sepsis.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda